Skip to main content
. 2016 Dec 2;5:223–235. doi: 10.1007/s40204-016-0060-8

Fig. 8.

Fig. 8

Plates showing the antibacterial activity of the fabricated CaP (a), CaP-AgNP-0.25 (b), CaP-AgNP-0.5 (c), CaP-AgNP-1 (d) against E. coli (plate A) and S. aureus (plate B). Gentamicin discs were used as the positive control (e)